Results 31 to 40 of about 87,339 (215)

Corrigendum to "Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency" [J. Chromatogr. B 1036-1037 (2016) 170-177]. [PDF]

open access: greenJ Chromatogr B Analyt Technol Biomed Life Sci, 2018
Thorsteinsdottir M   +11 more
europepmc   +3 more sources

Adenine Phosphoribosyltransferase from Monkey Liver

open access: hybridJournal of Biological Chemistry, 1969
T A Krenitsky   +3 more
openaire   +2 more sources

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

open access: yesHepatology, EarlyView., 2022
Improved mitochondrial activity, due to the lack of methylation‐controlled J protein (MCJ), creates a specific microbiota signature that when transferred through cecal microbiota transplantation delays NASH progression by restoring the gut‐liver axis and enhancing hepatic fatty acid oxidation.
María Juárez‐Fernández   +18 more
wiley   +1 more source

Inhibition of nicotinamide phosphoribosyltransferase, the rate-limiting enzyme of the nicotinamide adenine dinucleotide salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.

open access: yesNeuro-Oncology, 2021
BACKGROUND Tumor-specific metabolic processes essential for cell survival are promising targets to potentially circumvent intratumoral heterogeneity, a major resistance factor in gliomas.
Pratibha Sharma   +9 more
semanticscholar   +1 more source

2,8-Dihydroxyadenine nephrolithiasis with chronic kidney disease in children: A case report and review of literature

open access: yesUrology Case Reports, 2023
The incidence of nephrolithiasis in children ranges from 5 to 10% in developing countries. Etiology of nephrolithiasis in children remains largely unknown, so metabolic evaluation is indicated in all case, because of potential morbidity and recurrence ...
Rizky Ramdhani   +6 more
doaj   +1 more source

A Novel One-Pot Enzyme Cascade for the Biosynthesis of Cladribine Triphosphate

open access: yesBiomolecules, 2021
Cladribine triphosphate is the active compound of the anti-cancer and multiple sclerosis drug Mavenclad (cladribine). Biosynthesis of such non-natural deoxyribonucleotides is challenging but important in order to study the pharmaceutical modes of action.
Julia Frisch   +2 more
doaj   +1 more source

Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy

open access: yesFrontiers in Pharmacology, 2020
Nicotinamide adenine dinucleotide (NAD) is a cofactor of many enzymatic reactions as well as being a substrate for a number of NAD-consuming enzymes (e.g., PARPS, sirtuins, etc).
Ubaldina Galli   +5 more
doaj   +1 more source

Inflammation plays a critical role in 2,8-dihydroxyadenine nephropathy

open access: yesComptes Rendus. Chimie, 2021
Adenine phosphoribosyltransferase (APRT) deficiency is a genetic disease characterized by an increased production of 2,8 dihydroxyadenine (2,8-DHA) precipitating in urine, leading to a crystalline nephropathy and end-stage renal disease.
Bouderlique, Elise   +12 more
doaj   +1 more source

Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency. [PDF]

open access: yesJ Chromatogr B Analyt Technol Biomed Life Sci, 2016
Thorsteinsdottir M   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy